Andrew Huberman· PhD
GLP-1 Agonists, Cognition, Longevity, Tool: Habits Support Medication; Cycling (47:41)
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
GLP-1 Agonists, Cognition, Longevity, Tool: Habits Support Medication; Cycling (47:41)
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
GLP-1 Agonists, Diabetes, Tool: Muscle Maintenance & Resistance Training (38:40)
now a lot of people are very interested in these JLPs as possible longevity drugs and there are trials underway to look at this sort of stuff.
Could these treatments actually promote longevity?